echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Radiology: MRI radiomics pathological prediction after chemoradiotherapy for rectal cancer

    Radiology: MRI radiomics pathological prediction after chemoradiotherapy for rectal cancer

    • Last Update: 2022-05-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Total mesorectal resection following neoadjuvant chemotherapy (nCRT) is the current standard of care for patients with locally advanced rectal cancer (LARC); however, treatment response varies from no tumor regression to pathological complete response ( pCR) are very different


    Although MRI is the modality of choice for assessing and assessing nCRT response prior to initial treatment in patients with rectal cancer, intuitive assessment of pCR remains challenging due to relatively little consensus on the assessment of nCRT response by MRI


    Recently, a study published in the journal Radiology established a radiomics model using MRI (T2-weighted and DWI) as a potential imaging metric for predicting pCR after nCRT in LARC patients and evaluated their diagnostic performance based on qualitative assessments by radiologists.


    This retrospective study included patients with LARC (clinical stage T3 or higher, positive nodule status, or both) who underwent MRI and elective resection after nCRT between January 2009 and December 2018.


    Of the 898 patients, 189 (21%) achieved pCR


    Receiver operating characteristic curve analysis of radiomic scores predicting pathological complete response in (A) training and (B) testing groups


    Receiver operating characteristic curve analysis of radiomic scores predicting pathological complete response in (A) training and (B) testing groups


     

    Original source:

    Original source:

    Jaeseung Shin, Nieun Seo, Song-Ee Baek.


    Jaeseung Shin, Nieun Seo, Song-Ee Baek.
    MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
    DOI: 10.
    1148/radiol.
    211986.


    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.